[go: up one dir, main page]

RU2007122391A - S-миртазапин для лечения приливов - Google Patents

S-миртазапин для лечения приливов Download PDF

Info

Publication number
RU2007122391A
RU2007122391A RU2007122391/14A RU2007122391A RU2007122391A RU 2007122391 A RU2007122391 A RU 2007122391A RU 2007122391/14 A RU2007122391/14 A RU 2007122391/14A RU 2007122391 A RU2007122391 A RU 2007122391A RU 2007122391 A RU2007122391 A RU 2007122391A
Authority
RU
Russia
Prior art keywords
mirtazapine
treatment
hot flashes
tidal treatment
drug
Prior art date
Application number
RU2007122391/14A
Other languages
English (en)
Other versions
RU2396957C2 (ru
Inventor
Б.В.М.М. Бернардус ПЕТЕРС (NL)
Б.В.М.М. Бернардус Петерс
Антон Эгберт Петер АДАНГ (NL)
Антон Эгберт Петер Аданг
Original Assignee
Н.В. Органон (Nl)
Н.В. Органон
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2007122391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Н.В. Органон (Nl), Н.В. Органон filed Critical Н.В. Органон (Nl)
Publication of RU2007122391A publication Critical patent/RU2007122391A/ru
Application granted granted Critical
Publication of RU2396957C2 publication Critical patent/RU2396957C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1. Способ лечения приливов лекарственным средством, относящимся к миртазапину, характеризующийся тем, что лекарственное средство содержит чистый S-миртазапин в качестве активного ингредиента.2. Применение S-миртазапина для производства лекарственного средства для лечения приливов.

Claims (2)

1. Способ лечения приливов лекарственным средством, относящимся к миртазапину, характеризующийся тем, что лекарственное средство содержит чистый S-миртазапин в качестве активного ингредиента.
2. Применение S-миртазапина для производства лекарственного средства для лечения приливов.
RU2007122391/14A 2004-11-15 2005-11-14 S-миртазапин для лечения приливов RU2396957C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778.7 2004-11-15
EP04105778 2004-11-15

Publications (2)

Publication Number Publication Date
RU2007122391A true RU2007122391A (ru) 2008-12-20
RU2396957C2 RU2396957C2 (ru) 2010-08-20

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007122391/14A RU2396957C2 (ru) 2004-11-15 2005-11-14 S-миртазапин для лечения приливов

Country Status (30)

Country Link
US (4) US20070265245A1 (ru)
EP (1) EP1814555B1 (ru)
JP (1) JP2008519810A (ru)
KR (1) KR20070085470A (ru)
CN (2) CN102772414A (ru)
AR (1) AR053780A1 (ru)
AT (1) ATE439843T1 (ru)
AU (1) AU2005303778B2 (ru)
BR (1) BRPI0517818A2 (ru)
CA (1) CA2587283C (ru)
CY (1) CY1110538T1 (ru)
DE (1) DE602005016141D1 (ru)
DK (1) DK1814555T3 (ru)
ES (1) ES2329815T3 (ru)
HR (1) HRP20090513T1 (ru)
IL (1) IL182767A (ru)
MX (1) MX2007005827A (ru)
MY (1) MY144089A (ru)
NO (1) NO20072285L (ru)
NZ (1) NZ554858A (ru)
PE (1) PE20061051A1 (ru)
PL (1) PL1814555T3 (ru)
PT (1) PT1814555E (ru)
RS (1) RS51138B (ru)
RU (1) RU2396957C2 (ru)
SI (1) SI1814555T1 (ru)
TW (1) TW200631584A (ru)
UA (1) UA88655C2 (ru)
WO (1) WO2006051111A1 (ru)
ZA (1) ZA200703884B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
EP1993556A1 (en) * 2006-03-06 2008-11-26 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
MX2009005446A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro vaginal para mirtazapina.
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów
MX394876B (es) * 2017-05-25 2025-03-24 Glytech Llc Formulaciones para el tratamiento del trastorno de estres post-traumatico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
TW200631584A (en) 2006-09-16
HK1104235A1 (en) 2008-01-11
ZA200703884B (en) 2009-07-29
AU2005303778B2 (en) 2011-02-17
MY144089A (en) 2011-08-15
PE20061051A1 (es) 2006-10-26
IL182767A (en) 2011-07-31
NO20072285L (no) 2007-06-13
CA2587283A1 (en) 2006-05-18
SI1814555T1 (sl) 2009-12-31
CN102772414A (zh) 2012-11-14
PT1814555E (pt) 2009-09-30
CA2587283C (en) 2013-01-15
CN101056641A (zh) 2007-10-17
BRPI0517818A2 (pt) 2010-03-16
CY1110538T1 (el) 2015-04-29
DE602005016141D1 (de) 2009-10-01
RU2396957C2 (ru) 2010-08-20
ATE439843T1 (de) 2009-09-15
HRP20090513T1 (hr) 2009-10-31
UA88655C2 (ru) 2009-11-10
MX2007005827A (es) 2007-07-20
EP1814555B1 (en) 2009-08-19
PL1814555T3 (pl) 2010-01-29
RS51138B (sr) 2010-10-31
AU2005303778A1 (en) 2006-05-18
US20130225559A1 (en) 2013-08-29
US20120302552A1 (en) 2012-11-29
EP1814555A1 (en) 2007-08-08
ES2329815T3 (es) 2009-12-01
AR053780A1 (es) 2007-05-23
WO2006051111A1 (en) 2006-05-18
IL182767A0 (en) 2007-09-20
JP2008519810A (ja) 2008-06-12
US20100267694A1 (en) 2010-10-21
KR20070085470A (ko) 2007-08-27
US20070265245A1 (en) 2007-11-15
DK1814555T3 (da) 2009-12-07
NZ554858A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
DK3248600T3 (da) Kombinationer og måder til administration af terapeutiske stoffer og kombinationsterapi
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
SE0401342D0 (sv) Therapeutic compounds
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
ATE453642T1 (de) Substituierte phenylaminopyrimidine
TW200716628A (en) Novel compounds
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
RU2007122391A (ru) S-миртазапин для лечения приливов
CL2008002060A1 (es) Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras.
EA200970816A1 (ru) Новая лекарственная форма
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
ATE433459T1 (de) Desoxo-nonadepsipeptide
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE429435T1 (de) 7h-pyrrolopyrimidinderivate
RU2008129232A (ru) Способ лечения туберкулеза легких у больных вич-инфекцией
AR057155A1 (es) Metodo de administracion de la 5-(2-clorofenil)-1,2-dihidro-7-fluor-8-metoxi-3-metil-pirazolo[3,4-b][1,4]benzodiazepina
JP1764058S (ja) 医療用投薬準備システム用スタンド
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20111115